Table 1.
Total prevalence of patients treated with anti-diabetic medicine in Greenland and Denmark.
| Males, % (95 %-CI) (n/N) |
Females, % (95 %-CI) (n/N) |
Total, % (95 %-CI) (n/N) |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Age, years | GRL | DK | p (z-score) | GRL | DK | p (z-score) | GRL | DK | p (z-score) |
| 20–44 | 0.4 (0.3–0.6) (33/7,793) |
1.3 (1.3–1.3) (11,956/920,000) |
<0.001 (−6.82) |
0.5 (0.4–0.7) (39/7,248) |
1.5 (1.5–1.5) (13,448/895,845) |
<0.001 (−6.73) |
0.5 (0.4–0.6) (72/15,041) |
1.4 (1.4–1.4) (25,404/1,815,845) |
<0.001 (−9.60) |
| 45–49 | 1.3 (0.8–2.0) (22/1,677) |
4.0 (3.9–4.1) (8,174/203,825) |
<0.001 (−5.62) |
1.0 (0.6–1.7) (15/1,438) |
2.9 (2.8–3.0) (5,795/199,814) |
<0.001 (−4.19) |
1.2 (0.8–1.6) (37/3,115) |
3.5 (3.4–3.5) (13,969/403,639) |
<0.001 (−6.93) |
| 50–54 | 3.0 (2.3–3.9) (64/2,106) |
6.1 (6.0–6.2) (12,454/204,442) |
<0.001 (−5.84) |
2.3 (1.7–3.1) (42/1,833) |
4.2 (4.1–4.3) (8,467/201,332) |
<0.001 (−4.07) |
2.7 (2.2–3.2) (106/3,939) |
5.2 (5.1–5.2) (20,921/405,774) |
<0.001 (−6.98) |
| 55–59 | 3.6 (2.8–4.6) (64/1,754) |
8.5 (8.4–8.7) (15,323/179,791) |
<0.001 (−7.29) |
3.3 (2.4–4.4) (47/1,422) |
5.5 (5.4–5.7) (9,971/179,683) |
<0.001 (−3.69) |
3.5 (2.9–4.2) (111/3,176) |
7.0 (7.0–7.1) (25,294/359,474) |
<0.001 (−7.79) |
| 60–64 | 6.3 (5.0–7.8) (77/1,223) |
11.0 (10.9–11.2) (18,347/166,766) |
<0.001 (−5.25) |
5.4 (4.1–7.1) (53/975) |
7.0 (6.8–7.1) (11,850/170,093) |
0.061 (−1.87) |
6.0 (5.0–7.0) (130/2,198) |
9.0 (8.9–9.1) (30,197/336,859) |
<0.001 (−4.99) |
| 65–69 | 9.2 (7.2–11.3) (75/819) |
13.3 (13.1–13.4) (22,343/168,573) |
<0.001 (−3.45) |
8.7 (6.6–11.2) (53/612) |
8.4 (8.3–8.5) (14,737/175,775) |
0.803 (0.25) |
8.9 (7.5–10.5) (128/1,431) |
10.8 (10.7–10.9) (37,080/344,348) |
0.026 (−2.22) |
| 70–74 | 11.0 (8.6–13.8) (64/583) |
15.5 (15.3–15.7) (21,803/140,598) |
0.003 (−3.02) |
11.2 (8.5–14.4) (53/474) |
10.0 (9.8–10.1) (15,118/151,845) |
0.373 (0.89) |
11.1 (9.2–13.1) (117/1,057) |
12.6 (12.5–12.7) (36,921/292,443) |
0.128 (−1.52) |
| 75–79 | 14.9 (11.0–19.5) (43/289) |
15.8 (15.6–16.0) (14,057/89,001) |
0.667 (−0.43) |
14.2 (10.3–18.8) (40/282) |
11.2 (11.0–11.4) (11,737/104,872) |
0.112 (1.59) |
14.5 (11.7–17.7) (83/571) |
13.3 (13.2–13.5) (25,794/193,873) |
0.390 (0.87) |
| Total | 2.7 (2.5–3.0) (442/16,244) |
6.0 (6.0–6.0) (124,457/2,072,996) |
<0.001 (−17.58) |
2.4 (2.2–2.7) (342/14,284) |
4.4 (4.4–4.4) (91,123/2,079,259) |
<0.001 (−11.58) |
2.6 (2.4–2.8) (784/30,528) |
5.2 (5.2–5.2) (215,580/4,152,255) |
<0.001 (−20.62) |